We are fortunate to be located in one of the most vibrant and intellectual economies in the world. Current and past partners whose organizations are headquartered in Boston have included:
Beth Israel Deaconness Hospital
Boston Federal Reserve
Greater Boston Food Bank
TSA – Logan Airport
A catalyst for students to learn firsthand that there are countless careers in science and biotechnology. Biogen offers daylong, interactive science activities, intensive summer programs and opportunities to meet the “real” scientists of Biogen.
ABOUT OUR PARTNER
Biogen Inc., formerly Biogen Idec Inc., is a global biopharmaceutical company. The Company is focused on discovering, developing, manufacturing and delivering therapies for neurological, autoimmune and hematologic disorders. The Company develops, manufactures and markets products designed for the treatment of multiple sclerosis (MS) and hemophilia A and B. The Company’s marketed products include AVONEX, PLEGRIDY, TECFIDERA, TYSABRI, FAMPYRA for multiple sclerosis (MS), ALPROLIX for hemophilia B, and ELOCTATE for hemophilia A, among others. It also collaborates on the development and commercialization of RITUXAN (rituximab), which is a monoclonal antibody for the treatment of non-Hodgkin’s lymphoma, chronic lymphocytic leukemia and other conditions and share profits and losses for GAZYVA, which is for the treatment of chronic lymphocytic leukemia.